TY - JOUR
T1 - Three‐dimensional computer modeling as an aid to drug design
AU - Humblet, Christine
AU - Marshall, Garland R.
PY - 1981
Y1 - 1981
N2 - Three‐dimensional computer graphic systems are an emerging tool in the design of therapeutic compounds. The molecular recognition process involved in drug‐receptor interaction implies a three‐dimensional stereospecificity shared by a set of drugs of similar pharmacological action. In investigating the pharmacophore, it is therefore necessary to go beyond two‐dimensional structures by including the description of the spatial properties of drugs. This review describes both current and potential tools that a graphic computer can support to help the medicinal chemist in his structure‐activity puzzle. An outline of the systems presently in use for this purpose and a summary of recent applications is given. Some current developments undertaken in our research group are presented in the field of opiates, GABA, clonidine, antipsychotics, and S‐adenosyl‐L‐methionine inhibitors.
AB - Three‐dimensional computer graphic systems are an emerging tool in the design of therapeutic compounds. The molecular recognition process involved in drug‐receptor interaction implies a three‐dimensional stereospecificity shared by a set of drugs of similar pharmacological action. In investigating the pharmacophore, it is therefore necessary to go beyond two‐dimensional structures by including the description of the spatial properties of drugs. This review describes both current and potential tools that a graphic computer can support to help the medicinal chemist in his structure‐activity puzzle. An outline of the systems presently in use for this purpose and a summary of recent applications is given. Some current developments undertaken in our research group are presented in the field of opiates, GABA, clonidine, antipsychotics, and S‐adenosyl‐L‐methionine inhibitors.
KW - drug design
KW - graphic computer
KW - receptor modeling
UR - http://www.scopus.com/inward/record.url?scp=0019867977&partnerID=8YFLogxK
U2 - 10.1002/ddr.430010408
DO - 10.1002/ddr.430010408
M3 - Article
AN - SCOPUS:0019867977
VL - 1
SP - 409
EP - 434
JO - Drug Development Research
JF - Drug Development Research
SN - 0272-4391
IS - 4
ER -